Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 5
1988 1
1989 2
1990 1
1991 5
1992 2
1993 1
1994 2
1995 2
1996 5
1997 4
1998 6
1999 11
2000 10
2001 10
2002 7
2003 11
2004 9
2005 9
2006 14
2007 16
2008 12
2009 10
2010 13
2011 11
2012 17
2013 6
2014 9
2015 11
2016 10
2017 4
2018 3
2019 1
2020 5
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. Among authors: verheijen rh. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Free article. Clinical Trial.
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Van der Zee AG, et al. Among authors: verheijen rh. J Clin Oncol. 2008 Feb 20;26(6):884-9. doi: 10.1200/JCO.2007.14.0566. J Clin Oncol. 2008. PMID: 18281661 Free article. Clinical Trial.
Robotic surgery.
Schreuder HW, Verheijen RH. Schreuder HW, et al. Among authors: verheijen rh. BJOG. 2009 Jan;116(2):198-213. doi: 10.1111/j.1471-0528.2008.02038.x. BJOG. 2009. PMID: 19076952 Review.
Notch signaling in serous ovarian cancer.
Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR. Groeneweg JW, et al. Among authors: verheijen rh. J Ovarian Res. 2014 Nov 4;7:95. doi: 10.1186/s13048-014-0095-1. J Ovarian Res. 2014. PMID: 25366565 Free PMC article. Review.
Reply.
Verheijen RH. Verheijen RH. Gynecol Oncol. 2000 Aug;78(2):264. doi: 10.1006/gyno.2000.5898. Gynecol Oncol. 2000. PMID: 10926817 No abstract available.
Patient engagement in research on rare gynecological tumors.
Roze J, Groeneweg J, Monroe G, Fransen I, Gultekin M, Zweemer R, Verheijen RHM. Roze J, et al. Among authors: verheijen rhm. Int J Gynecol Cancer. 2020 Dec;30(12):2012-2014. doi: 10.1136/ijgc-2020-001555. Epub 2020 Jun 2. Int J Gynecol Cancer. 2020. PMID: 32487683 No abstract available.
Ovarian carcinogenesis: an alternative hypothesis.
Piek JM, van Diest PJ, Verheijen RH. Piek JM, et al. Among authors: verheijen rh. Adv Exp Med Biol. 2008;622:79-87. doi: 10.1007/978-0-387-68969-2_7. Adv Exp Med Biol. 2008. PMID: 18546620 Review.
[Trophoblastic diseases].
ten Kate-Booij MJ, Lok CA, Verheijen RH, Massuger LF, van Trommel NE. ten Kate-Booij MJ, et al. Among authors: verheijen rh. Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2219-24. Ned Tijdschr Geneeskd. 2008. PMID: 19009808 Review. Dutch.
Prognostic value of radiological recurrence patterns in ovarian cancer.
Roze JF, Veldhuis WB, Hoogendam JP, Verheijen RHM, Scholten RJPM, Zweemer RP. Roze JF, et al. Among authors: verheijen rhm. Gynecol Oncol. 2020 Jun;157(3):606-612. doi: 10.1016/j.ygyno.2020.03.003. Epub 2020 Mar 11. Gynecol Oncol. 2020. PMID: 32171567 Free article.
230 results